ACTUATE THERAPEUTICS, INC. (ACTU)
Latest ACTU Insider Trades
About ACTUATE THERAPEUTICS, INC. (ACTU)
Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3B, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.
- FORT WORTH, TX
- 12
- 2024
- XNAS
https://www.actuatetherapeutics.comSEC filings for ACTU on EDGAR
90-Day SEC Filing Activity
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Option exercise | 2 | 544,112 | |
| Tax withholding / forfeiture | 1 | 120,521 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
ACTU Insider Transactions (Form 4)
2015 Form 4 filings on record, the earliest from Apr 1, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Daniel M. Schmitt - Officer | Option exercise | Common Stock | 272,056 |
Recent ACTU Form 8-K Filings
4ACTU Insider Trading - FAQ
What is the latest insider trade for ACTU?
ACTUATE THERAPEUTICS, INC. (ACTU) had 1 insider filing in the last 90 days, with the most recent on 2026-08-14. The full record for ACTU runs to 15 Form 4 filings, the earliest from 2025-04-01. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying ACTU stock?
No insider purchases of ACTU were filed in the last 90 days.
How many insiders are selling ACTU stock?
No insider sales of ACTU were filed in the last 90 days. 1 sale is on record for this company.
Where can I see ACTU SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks ACTU Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow ACTU insider buys?
Create a free InsiderAlpha account and press Watch on this page to add ACTU to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - Daniel M. Schmitt view on EDGAR
- - Dan Zabrowski view on EDGAR
- - Todd S. Thomson view on EDGAR
- - Roger Sawhney view on EDGAR
- - Amy L. Ronneberg view on EDGAR
- - Jason A. Keyes view on EDGAR
- - Martin H. Huber Jr. view on EDGAR
- - Aaron G.L. Fletcher view on EDGAR
- - Daniel M. Schmitt view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where ACTU's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track ACTU insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
